| |
| |
|
| Insider
Information: |
Kumar Ravindra |
| Relationship: |
SVP & Chief Scientific... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
86,986 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,548,748 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
86,986 |
|
|
| Total
Value |
$15,548,748 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
SVP & Chief Scientific... |
2019-09-10 |
86,986 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2019-09-10 |
4 |
AS |
$45.24 |
$153,318 |
D/D |
(3,389) |
86,986 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2019-04-09 |
4 |
AS |
$44.24 |
$161,671 |
D/D |
(3,622) |
90,375 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,850 |
93,997 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2019-01-02 |
4 |
AS |
$42.45 |
$248,546 |
D/D |
(5,788) |
90,147 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2018-04-03 |
4 |
AS |
$38.34 |
$46,205 |
D/D |
(1,203) |
95,935 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,463 |
97,138 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2018-01-02 |
4 |
AS |
$42.41 |
$182,363 |
D/D |
(4,300) |
92,675 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2017-09-28 |
4 |
OE |
$5.28 |
$35,698 |
D/D |
6,761 |
96,975 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2017-09-13 |
4 |
AS |
$38.12 |
$305 |
D/D |
(8) |
90,214 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2017-09-12 |
4 |
AS |
$38.31 |
$196,113 |
D/D |
(5,105) |
90,222 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2017-08-08 |
4 |
AS |
$35.41 |
$462,632 |
D/D |
(13,065) |
95,327 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2017-08-08 |
4 |
OE |
$24.11 |
$314,997 |
D/D |
13,065 |
108,392 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2017-07-05 |
4 |
AS |
$32.00 |
$29,984 |
D/D |
(937) |
95,327 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2017-07-05 |
4 |
OE |
$7.12 |
$6,671 |
D/D |
937 |
96,264 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,900 |
95,327 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2017-01-04 |
4 |
AS |
$26.81 |
$54,916 |
D/D |
(2,000) |
88,427 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2016-12-22 |
4 |
OE |
$3.88 |
$70,497 |
D/D |
14,561 |
90,427 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2016-10-10 |
4 |
AS |
$34.14 |
$574,679 |
D/D |
(16,833) |
75,866 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2016-10-10 |
4 |
OE |
$7.12 |
$352,354 |
D/D |
16,833 |
92,699 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2016-10-07 |
4 |
AS |
$33.37 |
$655,538 |
D/D |
(19,644) |
75,866 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2016-10-07 |
4 |
OE |
$3.88 |
$186,040 |
D/D |
19,644 |
95,510 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2016-10-06 |
4 |
OE |
$5.28 |
$37,615 |
D/D |
7,124 |
91,875 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2016-10-06 |
4 |
AS |
$34.31 |
$550,315 |
D/D |
(16,009) |
75,866 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Scientific Officer |
• – – |
2016-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
84,751 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP & Chief Scientific Officer |
• – – |
2016-02-25 |
4 |
OE |
$3.88 |
$31,040 |
D/D |
8,000 |
78,751 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
